← Leaderboards
Enakshi D. Sunassee
Duke University
$178,860
Attributed
$178,860
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $95.1K · FY2023–25$100K$75K$50K$25K$0
'23
'24
'25
Funding mix
By agency
NIH$178,860 · 2
By mechanism
K00$95,074 · 1
F99$83,786 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Michael L Platt$32,235,020
- Kris C. Wood$5,294,947
- Joseph Heitman$44,576,851
- Jiyong Hong$5,518,476
- Lingchong You$13,458,703
Others in their field
Other Rising Stars on “Imaging Device”
- Frank A Provenzano · St. Joseph'S Hospital And Medical Center$8,533,907
- Brian J Lopresti · University Of Pittsburgh At Pittsburgh$6,934,890
- Joseph P. Uberti · Wayne State University$5,297,337
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Liang Liang · University Of Miami Coral Gables$3,714,558
- Kevin King · Turing Medical Technologies Inc$3,506,690
Research focus
Imaging DevicePaclitaxelGlycolysisImaging ApproachMetabolismNeoplastic CellGenetic TranscriptionCellsHeterogeneityImageIn VivoAftercareMolecularMonitorCell SurvivalCancer BiologyCancer CellCancer EtiologyChemotherapyCancer RecurrenceHypoxiaCause Of DeathBehaviorPatient Derived Xenograft Model
Grant awards (4)
Identifying vulnerabilities of ovarian cancer persister cells through integrated single-cell analyses$95,074
K00 · FY2025 · CA · contact PI
Understanding metabolic and vascular vulnerabilities of residual disease in triple negative breast cancer to inform on treatment strategies$41,783
F99 · FY2024 · CA · contact PI
Understanding metabolic and vascular vulnerabilities of residual disease in triple negative breast cancer to inform on treatment strategies$1,500
F99 · FY2024 · CA · contact PI
Understanding metabolic and vascular vulnerabilities of residual disease in triple negative breast cancer to inform on treatment strategies$40,503
F99 · FY2023 · CA · contact PI